Citizens Financial Group

CFG · NYSE

$64.22+$1.46 (+2.33%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $62.76

CFG analyst rating

BuyConsensus of 22 analysts over the last 12 months. 86% rate it a buy.

Strong buy1
Buy18
Hold3
Underperform0
Sell0

12-month price target · 19 analysts

Average $82.43 (+28.4% upside)

Low: $70.70
Now: $64.22
High: $93.45

Upgrades and downgrades

The latest rating actions, newest first

CFG analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Citigroup	Oct 20, 2026	Maintains	Buy	$84.00 → $74.00	40%
Truist Securities	Oct 20, 2026	Maintains	Hold	$77.00 → $70.00	59%
Stephens & Co.	Oct 20, 2026	Maintains	Equal-Weight	$70.00 → $65.00	63%
Morgan Stanley	Oct 19, 2026	Maintains	Overweight	$89.00 → $87.00	59%
RBC Capital	Oct 19, 2026	Maintains	Outperform	$79.00 → $74.00	67%
Cantor Fitzgerald	Oct 14, 2026	Maintains	Overweight	$84.00 → $78.00	54%
TD Cowen	Oct 8, 2026	Initiates	Buy	$75.00	50%
Raymond James	Oct 7, 2026	Initiates	Strong Buy	$77.00	54%
UBS	Oct 5, 2026	Maintains	Buy	$82.00 → $77.00	50%
JP Morgan	Oct 2, 2026	Maintains	Overweight	$78.00 → $72.50	46%

The case for and against

Updated Oct 21, 2026

Bull case

Citizens Financial Group is viewed favorably because it has transformed from an underinvested thrift into a more diversified, higher-quality franchise with stronger deposits, a growing commercial and capital markets presence, and a rapidly scaling Private Bank. Its 2Q26 results showed net income of $587 million, EPS of $1.30, ROTCE of 13.9%, NII of $1.631 billion, and a 3.17% NIM, while improving efficiency to 61.1% and keeping credit quality healthy with NCOs at 0.37%. The outlook remains constructive as management expects NIM expansion, continued Private Bank growth, and productivity gains from “Reimagine the Bank” to drive peer-leading EPS growth and support a path toward a 16% to 18% ROTCE by end of 2027.

Bear case

Citizens Financial Group is exposed to a difficult mix of credit, interest-rate, regulatory, and capital risks that can quickly pressure earnings, especially if borrowers weaken in a prolonged downturn or if funding costs rise faster than asset yields. While credit metrics improved in 2Q26, with net charge-offs falling to $135M or 37 bps and non-performing loans declining to $1.435B, the company still faces material office exposure and an ACL ratio of only 1.48%, leaving little room for surprise deterioration. Even with stronger Commercial Banking results and declining non-core runoff from $13.7B in 2Q23 to $1.6B in 2Q26, the outlook remains negative because margin compression, funding-cost volatility, and macro uncertainty could limit organic growth and profitability.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.